Showing results (121-130 of 196) with videos related to

Sort By:
Pageof 20
Blood Advances|November 10, 2022
Low toxicity and excellent outcomes in patients with DLBCL without residual lymphoma at the time of CD19 CAR T-cell therapyKitsada Wudhikarn, Ana Alarcon Tomas, Jessica R Flynn, et al.
Blood Advances|June 24, 2026
Late cytopenia after CD19 chimeric antigen receptor T cell in large B cell lymphoma: A Cell Therapy Consortium AnalysisKitsada Wudhikarn, Maria Bromberg, Jamie Brower, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 5, 2015
Outpatient Autologous Stem Cell Transplantation for Patients With MyelomaThomas M Paul, Stephen V Liu, Elise A Chong, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 20, 2022
Outcomes of Tisagenlecleucel in Lymphoma Patients With Predominant Management in an Ambulatory SettingSunita D Nasta, Mitchell E Hughes, Esin C Namoglu, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 12, 2010
NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on Treatment of Relapse after Allogeneic Hematopoietic Stem Cell TransplantationDavid L Porter, Edwin P Alyea, Joseph H Antin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 2, 2014
Improved survival after transplantation of more donor plasmacytoid dendritic or naïve T cells from unrelated-donor marrow grafts: results from BMTCTN 0201Edmund K Waller, Brent R Logan, Wayne A C Harris, et al.
Blood Advances|December 12, 2022
Chimeric antigen receptor T-cell therapy yields similar outcomes in patients with and without cytokine release syndromeShakthi T Bhaskar, Vivek G Patel, David L Porter, et al.
Clinical Transplantation|September 9, 2005
Serum protein electrophoresis abnormalities in adult solid organ transplant patients with post-transplant lymphoproliferative disorderDonald E Tsai, Nicole A Aqui, John E Tomaszewski, et al.
Future Oncology (London, England)|May 18, 2022
Process, resource and success factors associated with chimeric antigen receptor T-cell therapy for multiple myelomaDaanish Hoda, Robert Richards, Edward A Faber, et al.
Pageof 20